SLC22A4 (solute carrier family 22 member 4)

2011-07-01  

Identity

HGNC
LOCATION
5q31.1
LOCUSID
ALIAS
DFNB60,OCTN1

Other Information

Locus ID:

NCBI: 6583
MIM: 604190
HGNC: 10968
Ensembl: ENSG00000197208

Variants:

dbSNP: 6583
ClinVar: 6583
TCGA: ENSG00000197208
COSMIC: SLC22A4

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000197208ENST00000200652Q9H015

Expression (GTEx)

0
5
10
15
20
25
30

Pathways

PathwaySourceExternal ID
Choline metabolism in cancerKEGGhsa05231
Choline metabolism in cancerKEGGko05231
Transmembrane transport of small moleculesREACTOMER-HSA-382551
SLC-mediated transmembrane transportREACTOMER-HSA-425407
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compoundsREACTOMER-HSA-425366
Organic cation/anion/zwitterion transportREACTOMER-HSA-549132
Organic cation transportREACTOMER-HSA-549127

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA10804imatinibChemicalClinicalAnnotationassociatedPD22875622, 23127916
PA151958383Gastrointestinal Stromal TumorsDiseaseClinicalAnnotationassociatedPD22875622, 23127916
PA443890Diabetes Mellitus, Type 2DiseaseVariantAnnotationnot associatedPD
PA446171Leukemia, Myelogenous, Chronic, BCR-ABL PositiveDiseaseClinicalAnnotationassociatedPD22875622, 23127916
PA450395metforminChemicalVariantAnnotationnot associatedPD

References

Pubmed IDYearTitleCitations
380922322024OCTN1 (SLC22A4) displays two different transport pathways for organic cations or zwitterions.2
380922322024OCTN1 (SLC22A4) displays two different transport pathways for organic cations or zwitterions.2
381125742023Investigating the ID3/SLC22A4 as immune-related signatures in ischemic stroke.0
381125742023Investigating the ID3/SLC22A4 as immune-related signatures in ischemic stroke.0
349586792022The ergothioneine transporter (ETT): substrates and locations, an inventory.16
349586792022The ergothioneine transporter (ETT): substrates and locations, an inventory.16
329056462021DNA Methylation-Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia.10
329643102021Tooth loss and adiposity: possible role of carnitine transporter (OCTN1/2) polymorphisms in women but not in men.1
329056462021DNA Methylation-Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia.10
329643102021Tooth loss and adiposity: possible role of carnitine transporter (OCTN1/2) polymorphisms in women but not in men.1
315919052020LPS-induced inflammation delays the transportation of ASP(+) due to down-regulation of OCTN1/2 in alveolar epithelial cells.6
321493892020Cetirizine Reduces Gabapentin Plasma Concentrations and Effect: Role of Renal Drug Transporters for Organic Cations.2
315919052020LPS-induced inflammation delays the transportation of ASP(+) due to down-regulation of OCTN1/2 in alveolar epithelial cells.6
321493892020Cetirizine Reduces Gabapentin Plasma Concentrations and Effect: Role of Renal Drug Transporters for Organic Cations.2
309299222019Specificity of the ergothioneine transporter natively expressed in HeLa cells.13

Citation

Dessen P

SLC22A4 (solute carrier family 22 member 4)

Atlas Genet Cytogenet Oncol Haematol. 2011-07-01

Online version: http://atlasgeneticsoncology.org/gene/52522/slc22a4